ESC 365 - Impact of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes in cancer patients: a systematic review and meta-analysis of heart failure hospitalisation and mortality.

Open Access

Impact of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes in cancer patients: a systematic review and meta-analysis of heart failure hospitalisation and mortality.

Session: Managing cardiovascular risk in cancer patients

Topic: Cardio-Oncology

Speaker: Doctor J. Meng (Norwich, GB)

Event: ESC Preventive Cardiology 2024

Congress Presentation

Add to my library

About the speaker

Doctor James Meng

Norfolk And Norwich University Hospitals Nhs Foundation Trust, Norwich (United Kingdom of Great Britain & Northern Ireland)

0 follower

4 more presentations in this session

Cardiac rehabilitation and long-term prognosis in cardiovascular disease patients with cancer history

Speaker: Mr T. Miki (Sagamihara, JP)

Physiological determinants underlying a meaningful improvement in VO2peak following exercise training in anthracycline-treated breast cancer survivors

Speaker: Doctor S. Foulkes (Edmonton, CA)

Cardiovascular health profile of cancer survivors: real-world insights from the Polish Norwegian Study (PONS)

Speaker: Doctor G. Vaidean (Miami, US)

Peak oxygen uptake impairment in childhood cancer survivors treated with anthracycline-based chemotherapy: a systematic-review and meta-analysis

Speaker: Doctor S. Foulkes (Edmonton, CA)

Access the full session

Managing cardiovascular risk in cancer patients

Speakers: Doctor J. Meng, Mr T. Miki, Doctor S. Foulkes, Doctor G. Vaidean, Doctor S. Foulkes

About the event

ESC Preventive Cardiology 2024

25 April - 27 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources